Please use this identifier to cite or link to this item:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/10706
Full metadata record
???org.dspace.app.webui.jsptag.ItemTag.dcfield??? | Value | Language |
---|---|---|
dc.contributor.advisor | 陳為堅(Wei J. Chen) | |
dc.contributor.author | Ying-Ping Chen | en |
dc.contributor.author | 陳瑩萍 | zh_TW |
dc.date.accessioned | 2021-05-20T21:51:40Z | - |
dc.date.available | 2011-09-09 | |
dc.date.available | 2021-05-20T21:51:40Z | - |
dc.date.copyright | 2010-09-09 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-07-30 | |
dc.identifier.citation | REFERENCE
Al-Attar, S. A., Pollex, R. L., Ban, M. R., et al. Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample. Cardiovascular Diabetology (2008) 7:5. Austin, M. A., Edwards, K. L., McNeely, M. J., et al. Heritability of multivariate factors of the metabolic syndrome in nondiabetic Japanese americans. Diabetes (2004) 53(4):1166-1169. Barrett, J. C., Fry, B., Maller, J., et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2005) 21(2):263-265. Biernacka, J. M., Tang, R., Li, J., et al. Assessment of genotype imputation methods. BMC Proc (2009) 3 Suppl 7:S5. Chang, Y. C., Chang, T. J., Jiang, Y. D., et al. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population. Diabetes (2007) 56(10):2631-2637. Chang, Y. C., Liu, P. H., Lee, W. J., et al. Common variation in the fat mass and obesity-associated (FTO) gene confers risk of obesity and modulates BMI in the Chinese population. Diabetes (2008) 57(8):2245-2252. Chien, K. L., Lee, B. C., Hsu, H. C., et al. Prevalence, agreement and classification of various metabolic syndrome criteria among ethnic Chinese: A report on the hospital-based health diagnosis of the adult population. Atherosclerosis (2008) 196(2):764-771. Chuang, L. M. Human genetics of the metabolic syndrome. Asia Pac J Clin Nutr (2008) 17 Suppl 1:43-46. Chuang, L. M., Hsiung, C. A., Chen, Y. D., et al. Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance. J Mol Med (2001) 79(11):656-664. Cornier, M. A., Dabelea, D., Hernandez, T. L., et al. The metabolic syndrome. Endocr Rev (2008) 29(7):777-822. Dina, C., Meyre, D., Gallina, S., et al. Variation in FTO contributes to childhood obesity and severe adult obesity (vol 39, pg 724, 2007). Nature Genetics (2007) 39(10):1285-1285. Eckel, R. H., Grundy, S. M., and Zimmet, P. Z. The metabolic syndrome. Lancet (2005) 365(9468):1415-1428. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA (2001) 285(19):2486-97. Florez, J. C., Agapakis, C. M., Burtt, N. P., et al. Association testing of the protein tyrosine phosphatase 1B gene (PTPN1) with type 2 diabetes in 7,883 people. Diabetes (2005) 54(6):1884-1891. Frayling, T. M., Timpson, N. J., Weedon, M. N., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 316(5826):889-894. Freathy, R. M., Timpson, N. J., Lawlor, D. A., et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes (2008) 57(5):1419-1426. Freeman, M. S., Mansfield, M. W., Barrett, J. H., et al. Heritability of features of the insulin resistance syndrome in a community-based study of healthy families. Diabet Med (2002) 19(12):994-999. Gerken, T., Girard, C. A., Tung, Y. C., et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science (2007) 318(5855):1469-1472. Grant, S. F., Thorleifsson, G., Reynisdottir, I., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet (2006) 38(3):320-3. Groop, L. Genetics of the metabolic syndrome. Br J Nutr (2000) 83 Suppl 1:S39-48. Guo, T., Hanson, R. L., Traurig, M., et al. TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: analysis of 3,501 individuals. Diabetes (2007) 56(12):3082-3088. Gustafson, B., and Smith, U. Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J Biol Chem (2006) 281(14):9507-9516. Heid, I. M., Wagner, S. A., Gohlke, H., et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes (2006) 55(2):375-384. Heidema, A. G., Boer, J. M., Nagelkerke, N., et al. The challenge for genetic epidemiologists: how to analyze large numbers of SNPs in relation to complex diseases. BMC Genet (2006) 7:23. Henneman, P., Aulchenko, Y. S., Frants, R. R., et al. The genetic architecture of plasma adiponectin overlaps with the genetics of metabolic syndrome related traits. Diabetes Care (2010). Huang, C. H., Cong, L., Xie, J., et al. Rheumatoid arthritis-associated gene-gene interaction network for rheumatoid arthritis candidate genes. BMC Proc (2009) 3 Suppl 7:S75. Jiang, Y., Wilk, J. B., Borecki, I., et al. Common variants in the 5' region of the leptin gene are associated with body mass index in men from the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet (2004) 75(2):220-230. Li, Y., CJ, W., J, D., et al. Rapid Markov Chain Haplotyping and Genotype Inference. submitted (2006). Li, Y., CJ, W., J, D., et al. Genotype Imputation. Annu Rev Genomics Hum Genet (2009) 10:387-406. Li, Y., and GR, A. Mach 1.0: Rapid Haplotype Reconstruction and Missing Genotype Inference. Am J Hum Genet ( 2006) S79 2290. Liu, M., Guo, H. W., Wan, W. T., et al. [Association of peroxisome proliferator-activated-receptors-gamma C161-->T gene polymorphism with metabolic syndrome and dietary predisposition]. Zhonghua Yu Fang Yi Xue Za Zhi (2008) 42(7):494-8. Liu, P. H., Chang, Y. C., Jiang, Y. D., et al. Genetic variants of TCF7L2 are associated with insulin resistance and related metabolic phenotypes in Taiwanese adolescents and Caucasian young adults. J Clin Endocrinol Metab (2009) 94(9):3575-3582. Lo, S. H., Chernoff, H., Cong, L., et al. Discovering interactions among BRCA1 and other candidate genes associated with sporadic breast cancer. Proc Natl Acad Sci U S A (2008) 105(34):12387-12392. Lou, X. Y., Chen, G. B., Yan, L., et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet (2007) 80(6):1125-1137. Marzi, C., Huth, C., Kolz, M., et al. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys. Horm Metab Res (2007) 39(1):46-52. Mathieu, P., Pibarot, P., and Despres, J. P. Metabolic syndrome: the danger signal in atherosclerosis. Vasc Health Risk Manag (2006) 2(3):285-302. McGuire, M. C., Fields, R. M., Nyomba, B. L., et al. Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes (1991) 40(7):939-942. Meirhaeghe, A., Cottel, D., Amouyel, P., et al. Association between peroxisome proliferator-activated receptor gamma haplotypes and the metabolic syndrome in French men and women. Diabetes (2005a) 54(10):3043-3048. Meirhaeghe, A., Tanck, M. W., Fajas, L., et al. Study of a new PPARgamma2 promoter polymorphism and haplotype analysis in a French population. Mol Genet Metab (2005b) 85(2):140-148. Montagnana, M., Fava, C., Nilsson, P. M., et al. The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individuals. Diabet Med (2008) 25(8):902-908. Moore, J. H. A global view of epistasis. Nat Genet (2005) 37(1):13-14. Nedvidkova, J., Smitka, K., Kopsky, V., et al. Adiponectin, an adipocyte-derived protein. Physiological Research (2005) 54(2):133-140. Nothnagel, M., Ellinghaus, D., Schreiber, S., et al. A comprehensive evaluation of SNP genotype imputation. Hum Genet (2009) 125(2):163-171. Olivier, M., Hsiung, C. A., Chuang, L. M., et al. Single nucleotide polymorphisms in protein tyrosine phosphatase 1beta (PTPN1) are associated with essential hypertension and obesity. Hum Mol Genet (2004) 13(17):1885-1892. Palmer, N. D., Bento, J. L., Mychaleckyj, J. C., et al. Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes (2004) 53(11):3013-3019. Prestwich, T. C., and Macdougald, O. A. Wnt/beta-catenin signaling in adipogenesis and metabolism. Curr Opin Cell Biol (2007) 19(6):612-617. Qiao, B., Huang, C. H., Cong, L., et al. Genome-wide gene-based analysis of rheumatoid arthritisassociated interaction with PTPN22 and HLA-DRB1. BMC Proc (2009) 3(Suppl 7):S132. Ritchie, M. D., Hahn, L. W., Roodi, N., et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet (2001) 69(1):138-147. Ross, S. E., Hemati, N., Longo, K. A., et al. Inhibition of adipogenesis by Wnt signaling. Science (2000) 289(5481):950-953. Schousboe, K., Visscher, P. M., Henriksen, J. E., et al. Twin study of genetic and environmental influences on glucose tolerance and indices of insulin sensitivity and secretion. Diabetologia (2003) 46(9):1276-1283. Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science (2007) 316(5829):1341-1345. Semple, R. K., Chatterjee, V. K., and O'Rahilly, S. PPAR gamma and human metabolic disease. J Clin Invest (2006) 116(3):581-589. Spencer-Jones, N. J., Wang, X., Snieder, H., et al. Protein tyrosine phosphatase-1B gene PTPN1: selection of tagging single nucleotide polymorphisms and association with body fat, insulin sensitivity, and the metabolic syndrome in a normal female population. Diabetes (2005) 54(11):3296-3304. Tellechea, M. L., Aranguren, F., Perez, M. S., et al. Pro12Ala polymorphism of the peroxisome proliferatoractivated receptor-gamma gene is associated with metabolic syndrome and surrogate measures of insulin resistance in healthy men: interaction with smoking status. Circ J (2009) 73(11):2118-2124. Tregouet, D. A., and Garelle, V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics (2007) 23(8):1038-1039. Vasseur, F., Helbecque, N., Dina, C., et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Human Molecular Genetics (2002) 11(21):2607-2614. Vasseur, F., Meyre, D., and Froguel, P. Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies. Expert Rev Mol Med (2006) 8(27):1-12. Vaxillaire, M., Veslot, J., Dina, C., et al. Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes (2008) 57(1):244-254. Wright, W. S., Longo, K. A., Dolinsky, V. W., et al. Wnt10b inhibits obesity in ob/ob and agouti mice. Diabetes (2007) 56(2):295-303. Yang, L. L., Hua, Q., Liu, R. K., et al. Association between two common polymorphisms of PPARgamma gene and metabolic syndrome families in a Chinese population. Arch Med Res (2009) 40(2):89-96. Yang, W. S., and Chuang, L. M. Human genetics of adiponectin in the metabolic syndrome. J Mol Med (2006) 84(2):112-121. Yang, W. S., Yang, Y. C., Chen, C. L., et al. Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly. Am J Clin Nutr (2007) 86(2):509-513. Yi, F., Brubaker, P. L., and Jin, T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem (2005) 280(2):1457-1464. Zeggini, E., Parkinson, J. R., Halford, S., et al. Examining the relationships between the Pro12Ala variant in PPARG and Type 2 diabetes-related traits in UK samples. Diabet Med (2005) 22(12):1696-1700. Zheng, T., Wang, H., and Lo, S. H. Backward genotype-trait association (BGTA)-based dissection of complex traits in case-control designs. Human Heredity (2006) 62(4):196-212. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/10706 | - |
dc.description.abstract | 背景:偵測複雜性疾病的基因-基因交互作用為目前基因研究較受注目的部分。一般多使用以基因多型性為基礎之方法--generalized multifactor dimensionality reduction (GMDR) 偵測,其對高維度之基因-基因交互作用有較好的檢定力。但在同一基因上之基因多型性的相關功能性可能會導致使用GMDR時有偽陰性的結果產生。而使用以基因為基礎之方法可以捕捉到在同一個基因內的遺傳變異之交互作用。
目標:1) 從六個與代謝症候群因子相關之基因 (ADIPOQ, LEP, PPARG, FTO, TCF7L2, 及 PTPN1)的基因多型性中,尋找單獨基因多型性與代謝症候群之相關;2) 並利用GMDR及以基因為基礎之方式尋找是否有基因-基因交互作用存在。 方法:樣本來自於桃園縣年度成人健康檢查收集而來的611名40歲以上之代謝症候群病例及1117名對照。我們選出ADIPOQ, PPARG, LEP, TCF7L2, FTO 及PTPN1六個與代謝症候群危險因子相關之基因中的19個SNPs,尋找它們與代謝症候群之相關性,並使用generalized multifactor dimensionality reduction (GMDR) 方法及透過(genotype-trait distortion score, GTD score)的計算並以基因為基礎的方式探討是否有基因-基因交互作用的存在。 結果:在獨立相關分析部分,沒有SNP與代謝症候群相關。使用以基因為基礎的方式分析基因-基因交互作用時,透過GMDR得到PTPN1與ADIPOQ及TCF7L2有交互作用(交互驗證一致性為 4/10,permutation P = 0.01);而透過以基因為基礎之方法得到使用mean-ratio 方法時,可看到PTPN1分別和FTO及ADIPOQ有交互作用;而PTPN1和FTO的交互作用情形也可在quantile ratio看到。 結論: PTPN1在代謝症候群中是一個與ADIPOQ, TCF7L2和FTO有交互作用的重要因子,但這個潛在的生物機制仍須被探討並可能可以找出代謝症候群發生的新見解。 | zh_TW |
dc.description.abstract | Background: A growing focus in genetic studies of complex diseases is how to detect the joint effects of susceptibility genes. A common method is generalized multifactor dimensionality reduction (GMDR), which is Single Nucleotide Polymorphism (SNP)-based and has good power in identifying high-order gene-gene interactions. However, the functional relevance among the SNPs in the same gene may result in false negatives in using the GMDR. Instead, the gene-based method has been proposed to capture interactions that may involve such functional variants within a gene.
Objective: 1) To investigate whether there exist associations with the metabolic syndrome for individual SNPs in each of six genes that have been implicated because of their association with some components of the metabolic syndrome, including ADIPOQ, LEP, PPARG, FTO, TCF7L2, and PTPN1; and 2) to search for gene-gene interactions among these genetic loci on the metabolic syndrome by means of the GMDR as well as the gene-based analysis. Methods: A case-control study among participants of health check-up, aged 40 years or above, was carried out in Northern Taiwan, with a total of 611 cases with metabolic syndrome and 1117 controls. Among 19 SNPs of the six genes selected for this study, multivariable logistic regression analyses were used to estimate the association between individual SNPs and metabolic syndrome with adjustment for sex and age. Gene-gene interactions were then investigated using both the GMDR method and a gene-based approach that utilities the genotype-trait distortion score. Results: Individual SNPs did not exhibit significant association with metabolic syndrome. The gene-gene interaction analyses using the GMDR showed that a combination of SNPs in ADIPOQ, TCF7L2, and PTPN1 was the best model, with a prediction accuracy of 0.54 and a cross-validation consistency of 4/10 (permutation P = 0.01). Meanwhile, the gene-based analysis indicated that PTPN1 interacted with FTO, regardless of the type of ratio statistics (mean-ratio or quantile ratio) or the method used in assessing significance level (curve method or rank method), or with ADIPOQ if the curve method was used for the quantile ratio. Conclusions: Our results suggest that PTPN1 is an important gene that may interact with FTO, ADIPOQ, and TCF7L2 in exerting their influence on the metabolic syndrome. The underlying mechanism of the interaction warrants further investigation and may lead to new insights about the occurrence of the metabolic syndrome. | en |
dc.description.provenance | Made available in DSpace on 2021-05-20T21:51:40Z (GMT). No. of bitstreams: 1 ntu-99-R97842020-1.pdf: 505025 bytes, checksum: 6940730b1f97edbedbfdbda5991c0d76 (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | 口試委員會審定書 i
誌謝 ii 中文摘要 iii ABSTRACT iv CONTENT vi LIST OF TABLES vii LIST OF FIGURES viii INTRODUCTION 1 METHODS 4 RESULTS 10 DISSCUSION 12 REFERENCE 15 | |
dc.language.iso | en | |
dc.title | ADIPOQ, PPAR, LEP, TCF7L2, FTO及PTPN1基因多型性與代謝症候群之關聯與基因-基因交互作用: 社區為基礎之病例對照研究 | zh_TW |
dc.title | Individual Association and Gene-Gene Interaction among Genetic Variants of ADIPOQ, PPARG, LEP, TCF7L2, FTO and PTPN1 with Metabolic Syndrome in Taiwanese Adults: A Community-based Case-Control Study | en |
dc.type | Thesis | |
dc.date.schoolyear | 98-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 莊立民(Lee-Ming Chuang),楊欣洲(Hsin-Chou Yang),劉碧華(Pi-Hua Liu) | |
dc.subject.keyword | 基因-基因交互作用,GMDR,以基因為基礎之方式,代謝症候群, | zh_TW |
dc.subject.keyword | gene-gene interaction,GMDR,gene-based approach,metabolic syndrome, | en |
dc.relation.page | 30 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2010-07-30 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 流行病學研究所 | zh_TW |
Appears in Collections: | 流行病學與預防醫學研究所 |
Files in This Item:
File | Size | Format | |
---|---|---|---|
ntu-99-1.pdf | 493.19 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.